BiotechTube

NVXT topical + Placebo (Vehicle) Topical

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Onychomycosis

Conditions

Onychomycosis

Trial Timeline

Mar 21, 2016 → Jun 21, 2018

NCT ID
NCT02933879

About NVXT topical + Placebo (Vehicle) Topical

NVXT topical + Placebo (Vehicle) Topical is a phase 2 stage product being developed by Sun Pharmaceutical for Onychomycosis. The current trial status is completed. This product is registered under clinical trial identifier NCT02933879. Target conditions include Onychomycosis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02933879Phase 2Completed

Competing Products

20 competing products in Onychomycosis

See all competitors
ProductCompanyStageHype Score
NVXT Solution + Vehicle of test productSun PharmaceuticalPhase 2
52
SCH 56592 + SCH 56592 + SCH 56592 + SCH 56592 + Terbinafine + PlaceboMerckPhase 2
52
terbinafine + Placebo + terbinafine + PlaceboNovartisPhase 3
77
terbinafine hydrogen chloride + amorolfine nail lacquerNovartisPhase 3
77
terbinafine + Placebo + terbinafine + PlaceboNovartisPhase 3
77
AN2690PfizerPhase 2
51
AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + VehiclePfizerPhase 2
51
AN2690 Solution, 5.0% + AN2690 Solution, 7.5%PfizerPhase 2
51
AN2690 Topical Solution, 5% + Solution VehiclePfizerPhase 3
76
AN2690 + AN2690PfizerPhase 2
51
Tavaborole 5% Topical SolutionPfizerApproved
84
AN2690 Solution, 5.0%PfizerPhase 2
51
AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + AN2690 Solution VehiclePfizerPhase 2
51
AN2690PfizerPhase 2
51
AN2690 Topical Solution, 5% + Solution VehiclePfizerPhase 3
76
AN2690 + AN2690 + AN2690PfizerPhase 1
32
Albaconozole + Placebo + Albaconozole + Placebo + Albaconozole + PlaceboGSK plcPhase 1
32
Itraconazole 100mg capsules + Itraconazole 200mg tablets + Placebo tabletsGSK plcPhase 3
76
Albaconazole tablet 400mg + Albaconazole 100mg capsules, then albaconazole 400mg tabletGSK plcPhase 1
32
Albaconazole 100mg + Albaconazole 200mg + Albaconazole 400mg + Albaconazole 400mg + Placebo 400 mgGSK plcPhase 2
51

Other Products from Sun Pharmaceutical

Ilumya Injectable ProductApproved
85
CequaTM (Cyclosporine 0.09%) ophthalmic solutionApproved
85
Cyclosporine + Artificial tearApproved
85
AmifostineApproved
85
Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapyApproved
85